Status: no longer developing NGS platform
Sequenom acquired IP relating to NGS from Harvard University (based on Amit Meller’s work) in 2007 with the aim of developing their own NGS-based diagnostic platform. In 2010 they returned the technology to Harvard. While Sequenom is using NGS technology in developing their diagnostic products, they no longer appear to be pursuing the creation of their own platform. The IP they gave back to Harvard was combined with additional IP developed by Amit Meller while at Boston University to form the basis of NobleGen.
Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.